By indication / Receptor expression phenotyping
Receptor expression phenotyping
22 imaging agents and 5 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [68Ga]Ga-Pentixafor paired with [177Lu]Lu-pentixather | Ga-68 | Clinical research | 16 |
| [68Ga]Ga-RM2 paired with [111In]In-RM2 | Ga-68 | Clinical research | 7 |
| [18F]FES | F-18 | Approved | 5 |
| [111In]In-RM2 paired with [68Ga]Ga-RM2 | In-111 | Research | 2 |
| [18F]DK222 | F-18 | Research | 2 |
| [68Ga]Ga-ABY-025 | Ga-68 | — | 2 |
| [18F]GE-226 | F-18 | Research | 1 |
| [11C]PS13 | C-11 | Clinical research | 1 |
| [18F]AlF-NOTA-RD2 | F-18 | Preclinical | 1 |
| [18F]BTK-1 | F-18 | Preclinical | 1 |
| [68Ga]Ga-EMP100 | Ga-68 | — | 1 |
| [68Ga]PKB3 | Ga-68 | Reported once | 1 |
| [89Zr]DFO-11E10C11 | Zr-89 | Preclinical | 1 |
| [68Ga]TATE-46 | Ga-68 | Preclinical | 1 |
| [68Ga]TacBOMB2 | Ga-68 | Reported once | 1 |
| [68Ga]C803-GIP | Ga-68 | Reported once | 1 |
| [18F]AH113804 | F-18 | Research | |
| [18F]AlF | F-18 | — | |
| [68Ga]Ga-D0103 | Ga-68 | — | |
| [99mTc]Tc-N4-Bombesin | Tc-99m | Preclinical | |
| [89Zr]Zr-Df-pertuzumab-800CW | Zr-89 | — | |
| [18F]AlF-RESCA-5F7 | F-18 | Reported once |
Therapy
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [212Pb]Pb-DOTAMTATE | Pb-212 | Preclinical | 3 |
| [177Lu]Lu-DOTA-PP-F11N | Lu-177 | Clinical research | 2 |
| [225Ac]Ac-225-PRIT | Ac-225 | Preclinical | 2 |
| [177Lu]Lu-NeoBOMB1 | Lu-177 | — | 1 |
| [131I]I-131-PD-L1 | I-131 | — | 1 |
Other entries
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [57Co]Co-NOTA-PEG2-RM26 | Co-57 | Preclinical | 2 |
| [211At]At-(RGD)4 | At-211 | Preclinical |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region - tell us what you need.
Get in touch